Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04062214 · ClinicalTrials.gov registry record · NA
Pragmatic RCT of SBIRT-PM
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 1,101
- Enrollment target
NCT04062214: Completed NA study, sponsored by Yale University.
NCT04062214 is a NA study that has completed, run by Yale University. The registered enrollment target is 1,101 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (22% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04062214, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,101 participants
- Enrollment target
Study Summary
Veterans seeking compensation for musculoskeletal (MSD) conditions often develop chronic pain and are at high risk for substance misuse. The Investigators propose to test the effectiveness and cost-effectiveness of Screening, Brief Intervention and Referral to Treatment for Pain Management (SBIRT-PM), designed to reduce pain and reduce risky substance use, in part by helping Veterans get comprehensive pain treatment. The study will involve clinicians at a single site contacting Veterans throughout New England by phone to deliver SBIRT-PM counseling in a pragmatic, randomized, clinical trial.
Primary Outcome
Pain Intensity subscale of the Brief Pain Inventory uses a 0-10 numeric rating scale (0=no pain to 10=pain as bad as you can imagine) to measure four pain severity/intensity items: "worst" pain in the last 24 hours, "least" pain in the last 24 hours, "average" pain, and pain right "now". The pain intensity subscale is scored as a composite of the four pain items (mean intensity score).
Interventions
- BEHAVIORAL SBIRT-PM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,101 participants |
| Start Date | 2019-10-23 |
| Est. Completion | 2024-04-11 |
| Phase | NA |
What the finished NCT04062214 record still lists
NCT04062214 is an interventional study that assigns participants to a tested intervention. Its 1,101 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (22% lower).
The record links to 0 conditions, and to 1 intervention - of which SBIRT-PM is the first listed.
NCT04062214 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04062214 about?
NCT04062214 is a clinical study titled "Pragmatic RCT of SBIRT-PM". Veterans seeking compensation for musculoskeletal (MSD) conditions often develop chronic pain and are at high risk for substance misuse. The Investigators propose to test the effectiveness and cost-effectiveness of Screening, Brief Intervention and Referral to Treatment for Pain Management (SBIRT-PM...
What is the current status of trial NCT04062214?
This trial is currently completed. It is a NA study. The enrollment target is 1,101 participants. The study started on 2019-10-23. Estimated completion is 2024-04-11.
What interventions are being tested in trial NCT04062214?
The interventions under investigation include: SBIRT-PM (BEHAVIORAL).
Who is sponsoring clinical trial NCT04062214?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04062214's enrollment target sits among peer trials
1,101 93rd of 2000 higher than 1,908 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00710112 · 1,100 participants
Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants
- NCT02688517 · 1,100 participants
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
- NCT04743765 · 1,100 participants · NA
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
- NCT05638581 · 1,100 participants · Phase 3
Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI